BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4346935)

  • 1. Resistance to methylene dimethane sulphonate (MDMS) in L1210 cells in vitro.
    Anderson D; Nias AH
    Eur J Cancer (1965); 1972 Dec; 8(6):659-64. PubMed ID: 4346935
    [No Abstract]   [Full Text] [Related]  

  • 2. The establishment of MDMS-resistant cloned cell lines from in vitro cultured, MDMS-sensitive, Yoshida sarcoma cells.
    Szende B; Fox M
    Chem Biol Interact; 1973 Jan; 6(1):19-24. PubMed ID: 4347721
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of lymph node metastasis by thigh and footpad inoculation of mouse leukemia L-1210 cells.
    Tsukagoshi S; Inouye T; Sakurai Y
    Gan; 1973 Apr; 64(2):189-91. PubMed ID: 4353207
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity of fluorine-containing alkyl alkanesulfonates to cultured leukemia L1210 cells.
    Ohta Y; Kohda K; Kimoto H; Okano T; Kawazoe Y
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2410-6. PubMed ID: 2853650
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth in vitro of L-1210 leukemia in suspension culture.
    Kisielow P
    Arch Immunol Ther Exp (Warsz); 1970; 18(4):491-9. PubMed ID: 5483306
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
    Li LH; Olin EJ; Buskirk HH; Reineke LM
    Cancer Res; 1970 Nov; 30(11):2760-9. PubMed ID: 5487063
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells.
    Jami J; Ritz E
    J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938
    [No Abstract]   [Full Text] [Related]  

  • 8. The establishment of cloned cell lines from Yoshida sarcomas having differential sensitivities to methylene dimethane sulphonate in vivo and their cross-sensitivity to x-rays, UV and other alkylating agents.
    Fox M; Fox BW
    Chem Biol Interact; 1972 Apr; 4(5):363-75. PubMed ID: 5009846
    [No Abstract]   [Full Text] [Related]  

  • 9. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic changes associated with resistance to methotrexate and 6-mercaptopurine in L1210 ascites lymphoma.
    Calman NS; Eng B; Slater LM; Wallerstein H
    J Natl Cancer Inst; 1974 Mar; 52(3):997-8. PubMed ID: 4826575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
    Goncharova SA; Minenkova EA; Fomina MM; Demidova NS
    Eksp Onkol; 1984; 6(4):38-41. PubMed ID: 6499750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
    Geroni C; Pesenti E; Tagliabue G; Ballinari D; Mongelli N; Broggini M; Erba E; D'Incalci M; Spreafico F; Grandi M
    Int J Cancer; 1993 Jan; 53(2):308-14. PubMed ID: 8425770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of mouse erythroid colony formation by L1210 leukemia cells.
    Austin T; Ma A; Datta MC; Ortega JA; Shore NA; Dukes PP
    Exp Hematol; 1979 Feb; 7(2):63-73. PubMed ID: 428478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin.
    Chitnis MP; Joshi SS; Gude RP; Menon RS
    Chemotherapy; 1982; 28(3):209-12. PubMed ID: 7094661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
    Hanusovská E; Ujházy V
    Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in oncogenic potential of L1210 leukemia by triazenes.
    Schmid FA; Hutchison DJ
    Cancer Res; 1973 Sep; 33(9):2161-5. PubMed ID: 4725373
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of isopropyl methane sulphonate (IMS) on haemopoietic colony-forming cells.
    Schofield R; Lajtha LG
    Br J Haematol; 1973 Aug; 25(2):195-202. PubMed ID: 4353712
    [No Abstract]   [Full Text] [Related]  

  • 18. L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublines.
    Schmid FA; Otter GM; Hirano I
    Leuk Res; 1988; 12(1):67-70. PubMed ID: 3357349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 20. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.